リンパ浮腫診断の世界市場予測：リンシンシングラフィ、MRI、近赤外蛍光イメージング、超音波...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 33)
4.1 Lymphedema Diagnostics: Market Overview
4.2 Regional Analysis: Market, By Disease Type (2019)
4.3 Market, By Technology, 2019 vs 2024 (USD Million)
4.4 Near-Infrared Fluorescence Imaging Market, By Type, 2019 vs 2024 (USD Million)
4.5 Market, By Country
5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Global Prevalence of Lymphedema
5.2.1.2 Growing Global Prevalence of Cancer
5.2.1.3 Technological Advancements and Adoption of Newer Diagnostic Modalities
5.2.1.4 Increasing Investments, Funds, and Grants By Public-Private Organizations
5.2.2 Restraints
5.2.2.1 High Cost of Diagnostic Imaging Systems
5.2.2.2 Short Half-Life of Radiopharmaceuticals
5.2.2.3 Limited Supply of Helium
5.2.2.4 Increasing Adoption of Refurbished Diagnostic Imaging Systems
5.2.3 Opportunities
5.2.3.1 Emerging Countries
5.2.4 Challenges
5.2.4.1 Hospital Budget Cuts
6 Lymphedema Diagnostics Market, By Technology (Page No. – 45)
6.1 Introduction
6.2 Lymphoscintigraphy
6.2.1 Lymphoscintigraphy is Rapidly Developing to Be the First-Line Imaging Modality for Lymphedema Diagnostics
6.3 Magnetic Resonance Imaging
6.3.1 Magnetic Resonance Imaging Finds Major Applications in Lymphedema Treatment Planning
6.4 Ultrasound Imaging
6.4.1 Ultrasound Imaging has the Potential to Determine Tissue Changes Consistent With Different Stages of Lymphedema
6.5 Computed Tomography
6.5.1 High Cost of Computed Tomography to Limit Market Growth
6.6 X-Ray Lymphography
6.6.1 Invasive Nature & Risk of Radiation Exposure are Expected to Hamper Market Growth
6.7 Bioimpedance Analysis
6.7.1 Lack of Awareness About Bioimpedance Analysis is Limiting the Growth of This Segment
6.8 Near-Infrared Fluorescence Imaging
6.8.1 ICG Lymphography
6.8.1.1 ICG Lymphography Offers A Powerful Tool for Efficiently Diagnosing Various Stages of Lymphedema
6.8.2 Fluorescein Sodium Microlymphangiography
6.8.2.1 Fluorescein Sodium Microlymphangiography is Limited to Visualizing Only Initial Capillaries
7 Lymphedema Diagnostics Market, By Disease Type (Page No. – 59)
7.1 Introduction
7.2 Cancer
7.2.1 One in Three Cancer-Treated Patients Develop Lymphedema
7.3 Inflammatory Diseases
7.3.1 Growing Prevalence of Inflammatory Conditions to Drive Market Growth
7.4 Cardiovascular Disease
7.4.1 Growing Awareness About Early Disease Diagnosis to Drive the Adoption of Lymphedema Diagnostic Tools
7.5 Other Diseases
8 Lymphedema Diagnostics Market, By End User (Page No. – 64)
8.1 Introduction
8.2 Hospitals
8.2.1 The Large Number of Lymphedema Diagnostic Procedures Performed in Hospitals to Drive Market Growth
8.3 Diagnostic Centers
8.3.1 Increasing Number of Private Imaging Centers to Support Market Growth
8.4 Research & Academic Institutes
8.4.1 Budgetary Restrictions of Researchers are Limiting the Adoption of High-End Lymphedema Diagnostic Technologies
8.5 Other End Users
9 Lymphedema Diagnostics Market, By Region (Page No. – 69)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominated the North American Market in 2018
9.2.2 Canada
9.2.2.1 Dearth of Radiologists is Restricting Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany Accounts for the Largest Share of the European Market
9.3.2 France
9.3.2.1 Uncertainties With Regard to the Pricing Strategy of Diagnostic Companies to Limit Market Growth in France to A Certain Extent
9.3.3 UK
9.3.3.1 Rising Diagnostic Imaging Procedural Volumes Indicate Strong Growth in the UK Market
9.3.4 RoE
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Rising Disease Incidence, Increasing Procedural Volumes, and Growth in the Geriatric Population have Contributed to Market Growth in China
9.4.2 Japan
9.4.2.1 Japan’s Well-Established and Well-Equipped Healthcare System Ensures Demand for and Easy Access to Diagnostic Imaging
9.4.3 India
9.4.3.1 Growing Incidence of Lymphatic Filariasis is A Key Contributor to Market Growth
9.4.4 RoAPAC
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Latin America Holds the Largest Share of the RoW Market
9.5.2 Middle East & Africa
9.5.2.1 Growing Geriatric Population & Disease Prevalence are Driving Growth in Mea
10 Competitive Landscape (Page No. – 106)
10.1 Introduction
10.2 Ranking of Players, 2018
10.3 Competitive Scenario
10.4 Vendor Dive Overview
10.5 Vendor Inclusion Criteria
10.6 Vendor Dive
10.6.1 Visionary Leaders
10.6.2 Innovators
10.6.3 Dynamic Differentiators
10.6.4 Emerging Companies
11 Company Profiles (Page No. – 111)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 GE Healthcare
11.2 Siemens Healthineers (A Subsidiary of Siemens Group)
11.3 Philips
11.4 Canon, Inc.
11.5 Shimadzu Corporation
11.6 Stryker Corporation
11.7 Fluoptics
11.8 United Imaging Healthcare Co., Ltd.
11.9 Hitachi, Ltd.
11.10 Esaote SPA
11.11 Neusoft Corporation
11.12 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
11.13 Mitaka Usa, Inc.
11.14 Curadel, LLC
11.15 Impedimed Limited
11.16 Other Companies
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 158)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details